Inventor · disambiguated record
Jonathan Marchini
Also filed as: MARCHINI JONATHAN
1 granted patent·7 pending applications·0 citations·filing 2022–2024
13Inventor score
Files withREGENERON PHARMA8
Top patents by PatentIndex Score
8 records- 0170US2025197866A1Treatment Of Liver Disease With Mitochondrial Glycerol-3-Phosphate Acyltransferase (GPAM) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0264US12215322B2Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitorsREGENERON PHARMA·Filed 2022·Granted Feb 4, 2025·0 cites·3 claims
- 0363US2025092396A1Treatment Of Osteoarthritis With Cartilage Intermediate Layer Protein 2 (CILP2) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0461US2024247267A1Treatment Of Stroke With 1,4-Alpha-Glucan-Branching Enzyme (GBE1) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0561US2025129372A1Treatment Of Osteoarthritis With Procollagen Galactosyl Transferase 2 (COLGALT2) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0659US2023108957A1Treatment Of Psychiatric Disorders And Psychiatric Disorder-Associated MRI Phenotypes With Stabilin 1 (STAB1) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0758US2025136996A1Treatment of smoking with cholinergic receptor nicotinic beta 3 subunit (chrnb3) inhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0857US2023034093A1Treatment Of Cognitive Impairment With Alpha-N-Acetylgalactosaminide Alpha-2,6-Sialyltransferase 5 (ST6GALNAC5) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Marchini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →